Skip to content

Instant Message-delivered Cognitive Behavioural Therapy for Insomnia (CBT-I)Stroke Caregivers

The Effect of Instant Message-delivered Brief Cognitive Behavioural Therapy for Insomnia (CBT-I) in Stroke Family Caregivers: a Mixed Method Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05952245
Enrollment
138
Registered
2023-07-19
Start date
2023-12-01
Completion date
2025-03-31
Last updated
2024-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiver Burnout, Depressive Symptoms, Insomnia, Mobile Phone Use, Psychological Distress, Stroke

Brief summary

The proposed trial aims to assess the effectiveness of Cognitive-behavioural therapy for insomnia (CBT-I) based ecological momentary intervention (EMI) for reducing insomnia symptoms among stroke caregivers.

Detailed description

Existing studies reported that 40-95% of family caregivers had clinically significant insomnia symptoms including reduced total sleep duration, prolonged sleep onset latency, frequent night awakenings, and poor sleep efficiency and quality. Cognitive-behavioural therapy for insomnia (CBT-I) has shown a large effect in reducing insomnia among adults. Innovative and interactive technologies, such as Internet-delivered CBT-I (iCBT-T), have therefore been incorporated into CBT-I, which was identified to have similar effects to that of traditional CBT-I. In the proposed trial, screened stroke caregivers will be recruited from community centres, rehabilitation centres, and tertiary hospitals in HK. The intervention group will receive CBTI-based EMI through instant messaging applications as personalised and real-time psychological support led by nurses for 3 months. The control group will only receive stroke and brief sleep hygiene education with chat-based support on the topics.The primary outcomes are Sleep Condition Indicator (SCI) and Insomnia Severity Index (ISI) scores. Secondary outcomes will include sleep quality, depressive symptoms, anxiety symptoms, caregiver's burden, quality of life, and et al. A post-trial qualitative study will be conducted to understand the participants' experience of and compliance with the EMI.

Interventions

BEHAVIORALiCBTI-based EMI

Including brief iCBT-I for sleep support, stroke care education, and nurse-led real-time chat-based support messages, which were delivered according to participants' preferences (e.g., time and frequency).

BEHAVIORALEducation-based EMI

Stroke and brief sleep hygiene education with chat-based support on the topics.

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Primary family caregiver (Aged ≥18) of stroke survivor * Able to read and communicate in Chinese * Engaged caregiving roles for \> 4 hours per day; * Able to use a smartphone messaging app (e.g., WhatsApp and WeChat) * SCI ≤ 21 scores (i.e., clinically significant insomnia)

Exclusion criteria

* Has provided care for \<1 month prior to recruitment * Has a diagnosis of psychiatric disease or is currently taking psychotropic drugs * Currently taking medication to help with sleep * Currently participating in any type of psychological intervention

Design outcomes

Primary

MeasureTime frameDescription
Sleep Condition Indicator (SCI)24 weeksAn eight-item rating scale that was developed to screen for insomnia disorder based on DSM-5 criteria. Possible total score ranges from 0 to 32, with higher values indicative of better sleep.
Insomnia Severity Index (ISI)24 weeksA 7-item scale with scoring ranging from 0-28, a higher score indicate more severe insomnia symptoms

Secondary

MeasureTime frameDescription
Anxiety symptoms (Generalized Anxiety Disorder-7 [GAD-7])24 weeksA 7-item scale with score ranging from 0 to 21, higher scores indicate higher severity of anxiety symptom
Caregiver's burden (Zarit Burden Interview [ZBI-4])24 weeksA 4-item scale with score ranging from 0 to 16, higher scores indicate higher severity of caregiving burden
Quality of life (EuroQol 5-dimension 5-level questionnaire [EQ-5D-5L])24 weeksThe EQ-5D-5L assesses five health dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each rated on five levels of severity, with scores ranging from -0.864 to 1, where higher scores indicate better quality of life. Additionally, it includes a visual analogue scale (VAS), ranging from 0 (the worst health imaginable) to 100 (the best health imaginable).
Positive experiences from caregiving (Positive Aspect of Caregiving [PAC])24 weeksAn 11-item scale with scores ranging from 0 to 44. A higher score indicates a more positive caregiving experience.
Caregiving self-efficacy (Caregiving Self-Efficacy Scale [CSES-8])24 weeksAn 8-item scale with scores ranging from 1 to 10, with higher scores indicating higher self-efficacy.
Sleep parameters (Consensus Sleep Diary Core Version)24 weeksThe Consensus Sleep Diary Core Version will be used to collect sleep parameters (e.g., sleep efficiency and total sleep time).
Sleep quality (Pittsburgh Sleep Quality Index [PSQI])24 weeksA 19-item scale ranging from 0 to 21 with the higher total score (referred to as global score) indicating worse sleep quality
Sleep hygiene statue (Sleep Hygiene Index [SHI])24 weeksA 13-item scale with ratings from 0 to 52, where higher scores indicate poorer sleep hygiene status.
Sleep-related behavior (Chinese short-form of the sleep-related behavior questionnaire [SRBQ-SF])24 weeksA 23-item scale with scores ranging from 0 to 92. A higher score indicates more sleep-related safety behaviors.
State of sleep effort (Glasgow Sleep Effort Scale [GSES])24 weeksA 7-item scale with scores ranging from 0 to 14, where higher scores indicate greater effort to sleep over the past week.
Sleep-related quality of life (Glasgow Sleep Impact Index [GSII])24 weeksThe primary measureable outcomes for the GSII reflect VAS scores (0-100; with lower scores reflecting negative impact) for each of the three specified ranks, capturing impairment in the past two weeks. GSII reflect VAS scores (0-100; with lower scores reflecting negative impact) for each of the three
Feedback on iCBT-I intervention24 weeksFeedback on the sleep support programme will be collected, focusing on various aspects such as perceived usefulness and willingness to recommend the program. Each aspect will be evaluated using a 5-point Likert scale, where higher scores indicate more positive evaluations.
Adverse events24 weeksFeedback on adverse events related to the iCBT-I intervention, such as fatigue, will be collected.
Dysfunctional Beliefs and attitudes about Sleep (Dysfunctional Beliefs and attitudes about Sleep [DBAS])24 weeksA 16-item scale with scores ranging from 0 to 160, with higher scores indicating greater dysfunctional beliefs about sleep.
Depressive symptoms (Patient Health Questionnaire-9 [PHQ-9]):24 weeksA 9-item scale with score ranging from 0 to 27, higher scores indicate higher severity of depressive symptom

Countries

Hong Kong

Contacts

Primary ContactJung Jae LEE
leejay@hku.hk+852 3917 6971

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026